10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-039783`
Period End Date	20190930
Filing Date	20191104
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	tyme-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 50 Cash Flow Statement 42 Stockholders Equity 29

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$296.68K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$592.13K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$406.19K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.01M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.14M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.36K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.77K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$101.15K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$300.68K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$447.90K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$17.52M	USD	Point-in-time
Total assets	`Assets`	$17.59M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	103.95M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	111.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Accounts payable and other current liabilities (including $104,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.25M	USD	Point-in-time
Accounts payable and other current liabilities (including $104,000 and $325,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.69M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$428.24K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$369.50K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.50M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$858.61K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$597.34K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$60.01K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.21M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.64M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$1.45M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$26.66K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$4.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.85M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.28M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 111,950,937 issued and outstanding at September 30, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$11.20K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 111,950,937 issued and outstanding at September 30, 2019, 300,000,000 authorized, 103,946,048 issued and outstanding at March 31, 2019	`CommonStockValue`	$10.40K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$95.47M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$102.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-95.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.81M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.99M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.59M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.52M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$97.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$251.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$651.00K	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$249.00K	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$5.84M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.44M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.45M	USD	2 Qtrs
General and administrative (including $97,000, $251,000, $249,000 and $651,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.57M	USD	1 Quarter
General and administrative (including $97,000, $251,000, $249,000 and $651,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$6.58M	USD	2 Qtrs
General and administrative (including $97,000, $251,000, $249,000 and $651,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.28M	USD	2 Qtrs
General and administrative (including $97,000, $251,000, $249,000 and $651,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.13M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.25M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.42M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$13.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-13.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-12.42M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-81.15K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.02M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$147.50K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$67.26K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.43K	USD	1 Quarter
Interest expense	`InterestExpense`	$6.06K	USD	2 Qtrs
Interest expense	`InterestExpense`	$62.22K	USD	2 Qtrs
Interest expense	`InterestExpense`	$29.24K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$3.10M	USD	2 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-2.43K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$119.17K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$-6.06K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.32M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.91M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.44M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.65M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	111.95M	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-9.32M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.74M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.59K	USD	2 Qtrs
Depreciation	`Depreciation`	$4.74K	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$4.70M	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$3.07M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-81.15K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.02M	USD	2 Qtrs
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$465.28K	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-295.45K	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$634.47K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-200.43K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-595.71K	USD	2 Qtrs
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-147.22K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-416.29K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-443.61K	USD	2 Qtrs
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-242.65K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-557.32K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-636.64K	USD	2 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-17.32K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.57M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.90M	USD	2 Qtrs
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$597.34K	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$324.85K	USD	2 Qtrs
Proceeds from underwritten registered offering, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$3.34M	USD	2 Qtrs
Proceeds from underwritten registered offering, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$11.17M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.57M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.01M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.01M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.91M	USD	2 Qtrs
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$15.31M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$15.31M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$14.30M	USD	Point-in-time
Interest	`InterestPaidNet`	$6.06K	USD	2 Qtrs
Interest	`InterestPaidNet`	$62.22K	USD	2 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$22.27M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$20.77M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$3.34M	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$3.89M	USD	1 Quarter
Issuance of common stock from underwritten registered offering, net of associated expenses (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	8.00M	shares	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.45M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.18M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.52M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.72M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.32M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.19M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$22.27M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$7.31M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$20.77M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$11.99M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	111.95M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	103.95M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.